Authors
Loading...
Preclinical study demonstrates that cysteine cathepsins B, K, and S drive arterial wall degradation in cerebral aneurysms, suggesting cathepsin inhibition may prevent disease progression.
Aoki et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: